Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Neuronest Corp. is currently prosecuting a patent portfolio within the Medical Devices & Mechanical Engineering technology area. The data indicates 1 pending office action, which is being reviewed by a distinct examiner. This suggests that the company's current legal efforts are focused on a specific technical innovation. The prosecution is also contained within a distinct art unit, ensuring that the review process follows the specialized procedures of that group.
The busiest examiner for this portfolio is LANDEEN, BROGAN RANE, who is responsible for 1 busiest_examiner_pending office action. Having this individual as the sole examiner for the pending workload allows for a consistent and focused dialogue. This can be beneficial for the applicant, as it simplifies the communication process and allows for a more predictable prosecution timeline.
Practitioners should observe that the concentration of the portfolio under LANDEEN, BROGAN RANE in the medical device sector indicates a streamlined prosecution environment. With only 1 pending office action to manage, the company can focus its efforts on addressing the specific feedback provided by this examiner. This structure avoids the challenges of navigating multiple examiner viewpoints or varying art unit standards.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LANDEEN, BROGAN RANE | 1 | 28.6% | -33.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18101805 | SYSTEMS AND METHODS FOR ALTERING NEURAL RESPONSE USING SENSORY INPUT REDUCTION | LANDEEN, BROGAN RANE | — |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18101805 | SYSTEMS AND METHODS FOR ALTERING NEURAL RESPONSE USING SENSORY INPUT REDUCTION | LANDEEN, BROGAN RANE | 3791 | §103 | Final Rejection | — | Pending | Jan 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNeuronest Corp. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Brogan Rane Landeen has the most, with 1 of Neuronest Corp.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
